Clinical Trial Update: DS-5565 Phase III Study for Renal Impairment in Japanese Subjects [Phase 3]

View source ↗

Summary

Phase III study update for DS-5565 in renal impairment Japanese subjects has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain
• Post-herpetic Neuralgia

Drugs mentioned

• DS-5565 (DS-5565)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Diabetic Peripheral Neuropathic Pain, Post-herpetic Neuralgia | Phase 3 | Status: COMPLETED | Results posted: 2020-10-26